Empirical validation of the insomnia severity index in cancer patients
Empirical validation of the insomnia severity index in cancer patients
复制标题
DOI：
10.1002/pon.860
复制
发表时间：
2005-06-01
期刊：
影响因子：
3.6
通讯作者：
Ivers, H
中科院分区：
文献类型：
--
作者：
Savard, MH;Savard, J;Ivers, H
尽管癌症患者失眠的患病率升高，但缺乏简单有效的工具来评估这一特定问题。本研究的目的是实证验证失眠严重程度指数（ISI），并评估其筛选1670例癌症患者失眠的能力。研究结果支持ISI的内在一致性和时间稳定性。它的双组分因子结构在不同癌症诊断之间是明确和稳定的。该工具的结构效度也得到了各种睡眠测量和生活质量测量的相关性的支持。ISI对治疗变化也很敏感。ISI的临床截止评分为8分与检测睡眠困难的最佳灵敏度和特异性相关。总之，ISI似乎是一个很好的评估和筛选工具，在癌症的背景下。版权所有（c）2004年约翰威利父子有限公司。
Despite the elevated prevalence of insomnia in cancer patients, there is a lack of brief validated instruments for the evaluation of this particular problem in this population. The goal of this study is to empirically validate the Insomnia Severity Index (ISI) and to evaluate its ability to screen insomnia in 1670 cancer patients. The results support the internal consistency and temporal stability of the ISI. Its two-component factor structure is clear and stable between different cancer diagnoses. The construct validity of that instrument is also supported by correlations obtained with various measures of sleep and one measure of quality of life. The ISI is also sensitive to therapeutic changes. A clinical cut-off score of 8 on the ISI is associated with optimal sensitivity and specificity for the detection of sleep difficulties. In conclusion, the ISI appears to be an excellent evaluation and screening tool in the context of cancer. Copyright (c) 2004 John Wiley & Sons, Ltd.